| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Pieri L, Pieri M, Haefely... |
LSD as an agonist dopamine receptors in the striatum |
Nature |
1974 |
| Kelly PH |
Action of LSD on supersensitive mesolimic dopamine receptors |
British J.Pharmac. |
1975 |
| Da Prada M, Pieri L, Kell... |
Effects of 5,6-Dihydroxytryptamine and 5,7-Dihydroxytryptamine on the ... |
Ann.N.Y.Acad.Sci. |
1978 |
| Johnson M, Letter AA, Mer... |
Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamp... |
J Pharmacol Exp Ther |
1988 |
| O'Hearn E, Battaglia G, D... |
Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDM... |
J Neurosci |
1988 |
| Ricaurte GA, DeLanney LE,... |
Toxic effects of MDMA on central serotonergic neurons in the primate: ... |
Brain Res |
1988 |
| Ricaurte GA, DeLanney LE,... |
5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergi... |
Brain Res |
1988 |
| Ricaurte GA, Forno LS, Wi... |
(+/-)3,4-Methylenedioxymethamphetamine selectively damages central ser... |
JAMA |
1988 |
| Johnson M, Stone DM, Bush... |
Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced n... |
Eur J Pharmacol |
1989 |
| Stone DM, Hanson GR, Gibb... |
In vitro reactivation of rat cortical tryptophan hydroxylase following... |
J Neurochem |
1989 |
| Grob C, Bravo G, Walsh R |
Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxic... |
Arch Gen Psychiatry |
1990 |
| Scheffel U, Ricaurte GA |
Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamin... |
Brain Res |
1990 |
| Schmidt CJ, Abbate GM, Bl... |
Selective 5-hydroxytryptamine2 receptor antagonists protect against th... |
J Pharmacol Exp Ther |
1990 |
| Schmidt CJ, Kehne JH |
Neurotoxicity of MDMA: neurochemical effects |
Ann N Y Acad Sci |
1990 |
| Rattray M |
Ecstasy: towards an understanding of the biochemical basis of the acti... |
Essays Biochem |
1991 |
| Ricaurte GA, McCann UD |
Neurotoxic amphetamine analogues: effects in monkeys and implications ... |
Ann N Y Acad Sci |
1992 |
| Allen RP, McCann UD, Rica... |
Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, '... |
Sleep |
1993 |
| Jensen KF, Olin J, Haykal... |
Mapping toxicant-induced nervous system damage with a cupric silver st... |
NIDA Res Monogr |
1993 |
| Johnson M, Bush LG, Hanso... |
Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced... |
Biochem Pharmacol |
1993 |
| McCann UD, Ricaurte GA |
Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetam... |
J Clin Psychopharmac... |
1993 |
| Miller DB, O'Callaghan JP |
The interactions of MK-801 with the amphetamine analogues D-methamphet... |
Ann N Y Acad Sci |
1993 |
| Ricaurte GA, Markowska AL... |
3,4-Methylenedioxymethamphetamine, serotonin and memory [published err... |
J Pharmacol Exp Ther |
1993 |
| Robinson TE, Castaneda E,... |
Effects of cortical serotonin depletion induced by 3,4-methylenedioxym... |
Neuropsychopharmacol... |
1993 |
| Scanzello CR, Hatzidimitr... |
Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine ... |
J Pharmacol Exp Ther |
1993 |
| Tirzite D, Tirzitis G, Vi... |
Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced... |
Biochem Pharmacol |
1993 |
| McDowell DM, Kleber HD |
MDMA: Its history and pharmacology |
Psychiatric Annals |
1994 |
| Marsh JCW, Abboudi ZH, Gi... |
Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetami... |
Br J Haematol |
1994 |
| McCann UD, Ridenour A, Sh... |
Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (... |
Neuropsychopharmacol... |
1994 |
| Miller DB, O'Callaghan JP |
Environment-, drug- and stress-induced alterations in body temperature... |
J Pharmacol Exp Ther |
1994 |
| O'Callaghan JP, Miller DB |
Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mou... |
J Pharmacol Exp Ther |
1994 |
| Fischer C, Hatzidimitriou... |
Reorganization of ascending 5-HT axon projections in animals previousl... |
J Neurosci |
1995 |
| Green AR, Cross AJ, Goodw... |
Review of the pharmacology and clinical pharmacology of 3,4-methylened... |
Psychopharmacology (... |
1995 |
| McNamara MG, Kelly JP, Le... |
Some behavioural and neurochemical aspects of subacute (+/-)3,4-methyl... |
Pharmacol Biochem Be... |
1995 |
| Miller DB, O'Callaghan JP |
The role of temperature, stress, and other factors in the neurotoxicit... |
Mol Neurobiol |
1995 |
| McCann UD, Slate SO, Rica... |
Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'Ecsta... |
Drug Safety |
1996 |
| Seiden LS, Sabol KE |
Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possi... |
NIDA Res Monogr |
1996 |
| Colado MI, O'Shea E, Gran... |
In vivo evidence for free radical involvement in the degeneration of r... |
Br J Pharmacol |
1997 |
| Colado MI, O'Shea E, Gran... |
A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones ... |
Br J Pharmacol |
1997 |
| Tsatsakis AM, Michalodimi... |
MDEA related death in Crete: a case report and literature review |
Vet Hum Toxicol |
1997 |
| Huether G, Zhou D, Ruther... |
Causes and consequences of the loss of serotonergic presynapses elicit... |
J Neural Transm |
1997 |
| Colado MI, Granados R, O'... |
Role of hyperthermia in the protective action of clomethiazole against... |
Br J Pharmacol |
1998 |
| Bolla KI, McCann UD, Rica... |
Memory impairment in abstinent MDMA ('Ecstasy') users |
Neurology |
1998 |
| O'Shea E, Granados R, Est... |
The relationship between the degree of neurodegeneration of rat brain ... |
Neuropharmacology |
1998 |
| Sprague JE, Everman SL, N... |
An integrated hypothesis for the serotonergic axonal loss induced by 3... |
Neurotoxicology |
1998 |
| Plessinger MA |
Prenatal exposure to amphetamines. Risks and adverse outcomes in pregn... |
Obstet Gynecol Clin ... |
1998 |
| McCann UD, Szabo Z, Schef... |
Positron emission tomographic evidence of toxic effect of MDMA ('Ecsta... |
Lancet |
1998 |
| Stumm G, Schlegel J, Scha... |
Amphetamines induce apoptosis and regulation of bcl-x splice variants ... |
FASEB J |
1999 |
| Hatzidimitriou G, McCann ... |
Altered serotonin innervation patterns in the forebrain of monkeys tre... |
J Neurosci |
1999 |
| Beitia G, Cobreros A, Sai... |
3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: ef... |
Liver |
1999 |
| Sexton TJ, McEvoy C, Neum... |
(+) 3,4-methylenedioxymethamphetamine ('ecstasy') transiently increase... |
Mol Psychiatry |
1999 |
| McCann UD, Mertl M, Eligu... |
Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA... |
Psychopharmacology (... |
1999 |
| Colado MI, Esteban B, O'S... |
Studies on the neuroprotective effect of pentobarbitone on MDMA-induce... |
Psychopharmacology (... |
1999 |
| McCann UD, Eligulashvili ... |
Altered neuroendocrine and behavioral responses to m-chlorophenylpiper... |
Psychopharmacology (... |
1999 |
| Varela-Rey M, Montiel-Dua... |
3,4-methylenedioxymethamphetamine ('Ecstasy') stimulates the expressio... |
Biochem Biophys Res ... |
1999 |
| Sewell RA, Cozzi NV |
More about parkinsonism after taking ecstasy |
N Engl J Med |
1999 |
| Jayanthi S, Ladenheim B, ... |
Overexpression of human copper/zinc superoxide dismutase in transgenic... |
Neuroscience |
1999 |
| Mintzer S, Hickenbottom S... |
Parkinsonism after taking ecstasy [Comment & Reply] |
N Engl J Med |
1999 |
| Chang L, Grob C, Ernst T,... |
Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebr... |
Psychiatry Research ... |
2000 |
| Parrott AC, Sisk E, Turne... |
Psychobiological problems in heavy `ecstasy' (MDMA) polydrug users |
Drug Alcohol Depend |
2000 |
| Kuhn DM, Geddes TJ |
Molecular footprints of neurotoxic amphetamine action [In Process Cita... |
Ann N Y Acad Sci |
2000 |
| Reneman L, Booij J, Schma... |
Memory disturbances in 'Ecstasy' users are correlated with an altered ... |
Psychopharmacology (... |
2000 |
| Vollenweider FX, Gucker P... |
Effects of MDMA on 5-HT uptake sites using PET and [11C]-McN5652 in hu... |
Conference of the Ge... |
2000 |
| Brown JM, Hanson GR, Flec... |
Methamphetamine Rapidly Decreases Vesicular Dopamine Uptake |
Journal of Neurochem... |
2000 |
| Colado MI, O'Shea E, Este... |
Studies on the neuroprotective effect of the enantiomers of AR-A008055... |
Psychopharmacology (... |
2001 |
| Verkes RJ, Gijsman HJ, Pi... |
Cognitive performance and serotonergic function in users of ecstasy |
Psychopharmacology (... |
2001 |
| Carvalho M, Carvalho F, B... |
Is hyperthermia the triggering factor for the hepatoxicity induced by ... |
Arch Toxicol |
2001 |
| Mechan AO, O'Shea E, Elli... |
A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)... |
Psychopharmacology |
2001 |
| Reneman L, Lavalaye J, Sc... |
Cortical Serotonin Transporter Density and Verbal Memory in Individual... |
Archives of General ... |
2001 |
| Reneman L, Majoie CBLM, S... |
Pre-frontal N-acetylaspartate is strongly associated with memory perfo... |
Biological Psychiatr... |
2001 |
| Zakzanis K, Young DA |
Executive function in abstinent MDMA ('ecstasy') users |
Medical Science Moni... |
2001 |
| O'Loinsigh ED, Boland G, ... |
Behavioural, hyperthermic and neurotoxic effects of 3,4- methylenediox... |
Prog Neuropsychophar... |
2001 |
| Biello, SM, Dafters, RI |
MDMA and fenfluramine alter the response of the circadian clock to a s... |
Brain Research |
2001 |
| Reneman L, Booij J, de Br... |
Effects of dose, sex and long-term abstention from use on toxic effect... |
Lancet, |
2001 |
| Parrott AC |
Human psychopharmacology of ecstasy; A review of 15 years of empirical... |
Hum Psychopharm Clin... |
2001 |
| Heffernan TM, Jarvis H, R... |
Prospective memory, everyday cognitive failure and central executive f... |
Hum Psychopharm Clin... |
2001 |
| Daumann J, Pelz S, Becker... |
Psychological profile of abstinent recreational Ecstasy (MDMA) users a... |
Hum Psychopharmacol ... |
2001 |
| Buchert R, Obrocki J, Tho... |
Long-term effects of 'ecstasy' abuse on the human brain studied by FDG... |
Nucl Med Commun |
2001 |
| Buchert R, Obrocki J, Tho... |
Long-term effects of 'ecstasy' abuse on the human brain studied by FDG... |
Nucl Med Commun |
2001 |
| Parrott AC |
Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic ne... |
Pharmacol Biochem Be... |
2002 |
| Kish SJ |
How strong is the evidence that brain serotonin neurons are damaged in... |
Pharmacol Biochem Be... |
2002 |
| Leshner AI |
What should the public be told about the risks of Ecstasy? |
JAMA |
2002 |
| Mechan A, Moran PM, Ellio... |
A study of the effect of a single neurotoxic dose of 3,4-methylenediox... |
Psychopharmacology (... |
2002 |
| Reneman L, Majoie CB, Fli... |
Reduced N-acetylaspartate levels in the frontal cortex of 3,4- methyle... |
AJNR Am J Neuroradio... |
2002 |
| Johnson EA, Shvedova AA, ... |
d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxic... |
Brain Res |
2002 |
| Carvalho M, Carvalho F, R... |
Effect of 3,4-methylenedioxymethamphetamine ('ecstasy') on body temper... |
Arch Toxicol |
2002 |
| Fox HC, McLean A, Turner ... |
Neuropsychological evidence of a relatively selective profile of tempo... |
Psychopharmacology (... |
2002 |
| Meyer JS, Ali SF |
Serotonergic neurotoxicity of MDMA (ecstasy) in the developing rat bra... |
Ann N Y Acad Sci |
2002 |
| Holden C |
Drug find could give ravers the jitters |
Science |
2002 |
| Montoya AG, Sorrentino R,... |
Long-Term Neuropsychiatric Consequences of 'Ecstasy' (MDMA): A Review |
Harv Rev Psychiatry |
2002 |
| Hayner, GN |
MDMA misrepresentation: An unresolved problem for ecstasy users |
J Psychoactive Drugs |
2002 |
| Lange-Brock N, Berg T, Mu... |
[Acute liver failure following the use of ecstasy (MDMA)] |
Z Gastroenterol |
2002 |
| Montiel-Duarte C, Varela-... |
3,4-Methylenedioxymethamphetamine ("Ecstasy") induces apoptosis of cul... |
Biochim Biophys Acta |
2002 |
| Colbron S, Jones M, Biell... |
MDMA alters the response of the circadian clock to a photic and non-ph... |
Brain Res |
2002 |
| Colbron S, Jones M, Biell... |
MDMA alters the response of the circadian clock to a photic and non-ph... |
Brain Res |
2002 |
| Schmued LC |
Demonstration and localization of neuronal degeneration in the rat for... |
Brain Res |
2003 |
| Zhou JF, Zhou YH, Zhang L... |
3,4-methylenedioxymethamphetamine (MDMA) abuse markedly inhibits acety... |
Biomed Environ Sci |
2003 |
| Zhou JF, Chen P, Zhou YH,... |
3,4-Methylenedioxymethamphetamine (MDMA) abuse may cause oxidative str... |
Free Radic Res |
2003 |
| Cole JC, Sumnall HR |
Altered states: The clinical effects of Ecstasy |
Pharmacology and The... |
2003 |
| Curran HV, Verheyden SL |
Altered response to tryptophan supplementation after long-term abstent... |
Psychopharmacology (... |
2003 |
| Kish SJ |
What Is the Evidence That Ecstasy (MDMA) Can Cause Parkinson’s Disease... |
Movement Disorders |
2003 |
